Inside the race to turn one of cell biology’s least understood processes into a new foundation for drug development and ...

Curious about how protein crystallography fits into modern drug discovery? In this on-demand webinar, Dr. Thomas Pesnot from Concept Life Sciences chats with Dr. Debanu Das of Accelero Biostructure, ...

The most successful players — both old and new — are those focusing on operational risk control rather than assay novelty.

Additional $12M financing led by Elevage Medical Technologies and Jonathan Milner alongside existing investors British Business Bank, and GK Goh -- The funding will accelerate development of eProtein ...

A research team led by Prof. TAN Weihong and Prof. WU Qin from the Hangzhou Institute of Medicine (HIM) of the Chinese Academy of Sciences has developed a pioneering, multi-modal platform called SPARK ...

A platform to engineer enzymes responsible for the formation of amide bonds as an effort toward developing biocatalysts for green chemistry. Amide bonds — a type of chemical bond formed between a ...

Inhibrx develops next-generation protein therapeutics as nasdaq futures shape broader biotechnology discussions.

Nuclera has expanded its Series C funding round to USD $87 million following a new USD $12 million extension led by Elevage ...

The funding will support further development of eProtein Discovery to enable full-format antibody expression, purification, ...